ATC code M04
From Wikipedia, the free encyclopedia
(Redirected from QM04)
Pharmaceutical drug classification
| ATC code M: Musculo-skeletal system |
|---|
|
| Other ATC codes |
ATCcodeM04 Antigout preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1] [2] [3] Subgroup M04 is part of the anatomical group M Musculo-skeletal system.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM04.[5]
National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.
M04A Antigout preparations
[edit ]M04AA Preparations inhibiting uric acid production
[edit ]- M04AA01 Allopurinol
- M04AA02 Tisopurine
- M04AA03 Febuxostat
- M04AA51 Allopurinol, combinations
M04AB Preparations increasing uric acid excretion
[edit ]- M04AB01 Probenecid
- M04AB02 Sulfinpyrazone
- M04AB03 Benzbromarone
- M04AB04 Isobromindione
- M04AB05 Lesinurad
- M04AB06 Dotinurad
M04AC Preparations with no effect on uric acid metabolism
[edit ]- M04AC01 Colchicine
- M04AC02 Cinchophen
- M04AC51 Colchicine and probenecid
M04AX Other antigout preparations
[edit ]- M04AX01 Urate oxidase
- M04AX02 Pegloticase
References
[edit ]- ↑ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health . Retrieved 1 February 2020.
- ↑ "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization . Retrieved 3 January 2022.
- ↑ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ↑ "ATC/DDD Index 2022: code M04". WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ "ATCvet Index 2022: code QM04". WHO Collaborating Centre for Drug Statistics Methodology.